# A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole

> **NCT01165125** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 18 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** FF / GW642444
- **DRUG:** ketoconazole
- **DRUG:** ketoconazole (placebo to match)

## Key facts

- **NCT ID:** NCT01165125
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-01
- **Primary completion:** 2010-08-28
- **Final completion:** 2010-08-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165125, "A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01165125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*